US FDA approves Mirum Pharmaceuticals' drug for rare bone disorder
The FDA said the drug is approved to treat a rare bone disorder.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
US FDA approves Mirum's drug for rare bone disorder
The US Food and Drug Administration has approved Mirum Pharmaceuticals' NASDAQ:MIRM drug to treat a rare bone disorder, the regulator said on Friday.